BOI:EPA
Boiron SA
17,95 €
arrow_downward
-0,28%(-0,050) 1D
21 հոկ, 17:35:10 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
18,10 €
High
18,10 €
Low
17,45 €
Mkt. cap
312,43 մլն
Avg. vol.
5,50 հզր
Volume
0,00
P/E ratio
11,90
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
Open
18,10 €
High
18,10 €
Low
17,45 €
Mkt. cap
312,43 մլն
Avg. vol.
5,50 հզր
Volume
0,00
P/E ratio
11,90
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Simply Wall Street
·
7 րոպե առաջ
Amkor Technology (AMKR) Expands South Korea Capacity For AI Chip Packaging
Moomoo
·
38 րոպե առաջ
Dow Jones Top Markets Headlines at 9 PM ET: SpaceX, Anthropic and Nvidia Help Snap Tech Stocks Out of Their Recent Malaise | Canada ...
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA